Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70 mg/ colecalciferol 140ug tablets and 1250mg calcium carbonate tablets composite pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

calcium carbonate, Quantity: 1.2492 g (Equivalent: calcium, Qty 500 mg)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

alendronate sodium,colecalciferol,Calcium carbonate

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: magnesium stearate; hypromellose; sodium lauryl sulfate; dibasic sodium phosphate; monobasic sodium phosphate; titanium dioxide; croscarmellose sodium; macrogol 8000; polydextrose; indigo carmine aluminium lake; pregelatinised maize starch

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

4 weekly supply (4 x Alendronate Plus D3 70 mg/140 ug tablets and 48 x Calcium carbonate 1250 mg tablets)

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Alendronate/vitamin D3 and calcium composite pack is indicated for the treatment of:,? Osteoporosis* in select patients where vitamin D and calcium supplementation is recommended,* Prior to treatment, osteoporosis must be confirmed by: ? the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by ? the presence of osteoporotic fracture

Sommarju tal-prodott:

Visual Identification: Blue, modified oval, biconvex, film coated tablets engraved APO-CAL on one side, other side plain; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-05-05